Subscribe to our newsletter and benefit from the latest news on cold chain logisticsRegister
Download the Product CatalogueDownload
The medicine market is enjoying strong growth with increasing numbers of heat-sensitive products whose medicinal properties must be preserved. A few figures.
In 2012, the medicine market was valued at over 880 million dollars. The forecast for 2014 stands at 1,000 billion dollars. It is a constantly developing market boasting a 400% increase in 10 years.
The main consumers of medicines are North America and Europe (over 60% of the market). The United States are the greatest consumers of medicines with 38% of the global market. The European market (18% of global figures) is dominated by Germany and France.
The pharmaceutical industry regularly grows by 6% every year. This can be explained by the increase in the number of people suffering from diseases and health issues such as:
Treatments are developed for these growing illnesses. The percentage of heat-sensitive medicines will also grow, for several reasons: pharmaceutical lab mergers/acquisitions, development of R&D departments, 40 to 60% of patents entering the public domain, strong growth of the global generic market (availability for patients of targeted products developed by biotechnology), etc.
On the one hand, pharmaceutical companies must choose high-performance cold chain packaging that guarantees the medicinal properties of the products shipped. The Frizbox® temperature-controlled pallet shipper guarantees cold chain integrity for shipping large volumes all over the world.
On the other hand, it is important to inform patients and equip them for the correct transportation of their heat-sensitive medicines. The Nomad® range is specifically designed for them (insulated pouch, cooling bag…).
Sources : LEEM, L’économie du Médicament, July 2012 / FNIM, Le marché de l’industrie pharmaceutique, May 2012